Abstract
GEN EdgeVol. 5, No. 1 TopicASGCT News: Siren Biotechnology Hails Universal Gene Therapy for OncologyNicole Paulk, PhD, emerges from stealth to unveil her Bay area start-up that integrates AAV gene therapy with cytokine immunotherapy to reimagine the elimination of tumor cells and the induction of anti-tumor immunityJonathan D GrinsteinJonathan D GrinsteinSearch for more papers by this authorPublished Online:17 May 2023https://doi.org/10.1089/genedge.5.1.74AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 5Issue 1Jan 2023 Information© 2023 by GEN PublishingTo cite this article:Jonathan D Grinstein.ASGCT News: Siren Biotechnology Hails Universal Gene Therapy for Oncology.GEN Edge.Jan 2023.382-386.http://doi.org/10.1089/genedge.5.1.74Published in Volume: 5 Issue 1: May 17, 2023PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
